| molecular function |
| | GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| | GO:0005178 | | integrin binding | | Interacting selectively and non-covalently with an integrin. |
| | GO:0004726 | | non-membrane spanning protein tyrosine phosphatase activity | | Catalysis of the reaction: non-membrane spanning protein tyrosine phosphate + H2O = non-membrane spanning protein tyrosine + phosphate. |
| | GO:0016791 | | phosphatase activity | | Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate. |
| | GO:0004721 | | phosphoprotein phosphatase activity | | Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| | GO:0004725 | | protein tyrosine phosphatase activity | | Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| | GO:0030971 | | receptor tyrosine kinase binding | | Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity. |
| | GO:0019905 | | syntaxin binding | | Interacting selectively and non-covalently with a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse. |
| biological process |
| | GO:0030183 | | B cell differentiation | | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
| | GO:0030217 | | T cell differentiation | | The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
| | GO:0016311 | | dephosphorylation | | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
| | GO:0030218 | | erythrocyte differentiation | | The process in which a myeloid precursor cell acquires specializes features of an erythrocyte. |
| | GO:0042593 | | glucose homeostasis | | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
| | GO:0008286 | | insulin receptor signaling pathway | | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
| | GO:0070373 | | negative regulation of ERK1 and ERK2 cascade | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0050860 | | negative regulation of T cell receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
| | GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| | GO:0050922 | | negative regulation of chemotaxis | | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. |
| | GO:0042059 | | negative regulation of epidermal growth factor receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
| | GO:0050728 | | negative regulation of inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
| | GO:0046627 | | negative regulation of insulin receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. |
| | GO:0060336 | | negative regulation of interferon-gamma-mediated signaling pathway | | Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor. |
| | GO:1902206 | | negative regulation of interleukin-2-mediated signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-2-mediated signaling pathway. |
| | GO:1902215 | | negative regulation of interleukin-4-mediated signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-4-mediated signaling pathway. |
| | GO:0070104 | | negative regulation of interleukin-6-mediated signaling pathway | | Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of interleukin-6 binding to a cell surface receptor. |
| | GO:0010888 | | negative regulation of lipid storage | | Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
| | GO:1902227 | | negative regulation of macrophage colony-stimulating factor signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor signaling pathway. |
| | GO:0045650 | | negative regulation of macrophage differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage differentiation. |
| | GO:2000587 | | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway. |
| | GO:1902233 | | negative regulation of positive thymic T cell selection | | Any process that stops, prevents or reduces the frequency, rate or extent of positive thymic T cell selection. |
| | GO:1902212 | | negative regulation of prolactin signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of prolactin signaling pathway. |
| | GO:0061099 | | negative regulation of protein tyrosine kinase activity | | Any process that decreases the rate, frequency, or extent of protein tyrosine kinase activity. |
| | GO:0010804 | | negative regulation of tumor necrosis factor-mediated signaling pathway | | Any process that decreases the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor. |
| | GO:0060339 | | negative regulation of type I interferon-mediated signaling pathway | | Any process that decreases the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor. |
| | GO:0035335 | | peptidyl-tyrosine dephosphorylation | | The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine. |
| | GO:1903899 | | positive regulation of PERK-mediated unfolded protein response | | Any process that activates or increases the frequency, rate or extent of the PERK-mediated unfolded protein response. |
| | GO:1902237 | | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
| | GO:0045722 | | positive regulation of gluconeogenesis | | Any process that activates or increases the frequency, rate or extent of gluconeogenesis. |
| | GO:0006470 | | protein dephosphorylation | | The process of removing one or more phosphoric residues from a protein. |
| | GO:1902202 | | regulation of hepatocyte growth factor receptor signaling pathway | | Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. |
| | GO:0060334 | | regulation of interferon-gamma-mediated signaling pathway | | Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor. |
| cellular component |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| | GO:0005793 | | endoplasmic reticulum-Golgi intermediate compartment | | A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi and Golgi-to-ER transport. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |